Lauren Dembeck, PhD

Researchers sought to determine if there are racial disparities in treatment with bone-modifying agents for patients with multiple myeloma.

Researchers sought to determine whether blinatumomab followed by POMP maintenance chemotherapy would be safe and effective in older patients with B-ALL.

Researchers sought to determine the predictors of mortality during hospital stays in patients with multiple myeloma.